Cargando…
Comment on: Gudu T, Stober C, Cope AP et al. Baricitinib set to join the Covid-19 therapeutic arsenal?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135491/ https://www.ncbi.nlm.nih.gov/pubmed/33895812 http://dx.doi.org/10.1093/rheumatology/keab386 |
| _version_ | 1783695347008143360 |
|---|---|
| author | Khan, Sujoy |
| author_facet | Khan, Sujoy |
| author_sort | Khan, Sujoy |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8135491 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81354912021-05-21 Comment on: Gudu T, Stober C, Cope AP et al. Baricitinib set to join the Covid-19 therapeutic arsenal? Khan, Sujoy Rheumatology (Oxford) Published Online Only Oxford University Press 2021-04-25 /pmc/articles/PMC8135491/ /pubmed/33895812 http://dx.doi.org/10.1093/rheumatology/keab386 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Published Online Only Khan, Sujoy Comment on: Gudu T, Stober C, Cope AP et al. Baricitinib set to join the Covid-19 therapeutic arsenal? |
| title | Comment on: Gudu T, Stober C, Cope AP et al. Baricitinib set to join the Covid-19 therapeutic arsenal? |
| title_full | Comment on: Gudu T, Stober C, Cope AP et al. Baricitinib set to join the Covid-19 therapeutic arsenal? |
| title_fullStr | Comment on: Gudu T, Stober C, Cope AP et al. Baricitinib set to join the Covid-19 therapeutic arsenal? |
| title_full_unstemmed | Comment on: Gudu T, Stober C, Cope AP et al. Baricitinib set to join the Covid-19 therapeutic arsenal? |
| title_short | Comment on: Gudu T, Stober C, Cope AP et al. Baricitinib set to join the Covid-19 therapeutic arsenal? |
| title_sort | comment on: gudu t, stober c, cope ap et al. baricitinib set to join the covid-19 therapeutic arsenal? |
| topic | Published Online Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135491/ https://www.ncbi.nlm.nih.gov/pubmed/33895812 http://dx.doi.org/10.1093/rheumatology/keab386 |
| work_keys_str_mv | AT khansujoy commentongudutstoberccopeapetalbaricitinibsettojointhecovid19therapeuticarsenal |